NCT05291169View on ClinicalTrials.gov

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

March 1, 2024

Conditions
Venous Leg Ulcer
Interventions
DEVICE

Omeza® OCM™

"Omeza® OCM™ is a wound care matrix comprised of coldwater fish peptides (device) and cod liver oil (drug).~OCM™is supplied in a sterile single use vial."

Trial Locations (7)

15146

Serena Group, Monroeville

16201

ACMH Wound Clinic, Kittanning

16226

The Foot and Ankle Wellness Center of Western Pennsylvania, Ford City

33021

Royal Research, Corp, Hollywood

34289

Three Rivers Wound and Hyperbaric Center, North Port

74135

Wound Care of Tulsa, Tulsa

90063

New Hope Podiatry, Los Angeles

All Listed Sponsors
lead

Omeza, LLC

INDUSTRY